Post-effective Amendment to Registration Statement (pos Am)
July 14 2017 - 7:02AM
Edgar (US Regulatory)
As
filed with the Securities and Exchange Commission on July 14, 2017.
Registration
No. 333-214863
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
POST-EFFECTIVE
AMENDMENT NO. 1 TO FORM S-1
REGISTRATION
STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
MEDICAL
TRANSCRIPTION BILLING, CORP.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
7389
|
|
22-3832302
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(Primary
Standard Industrial
Classification
Code Number)
|
|
(I.R.S.
Employer
Identification
Number)
|
7
Clyde Road
Somerset,
New Jersey 08873
(732)
873-5133
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Mahmud
Haq
Chief Executive Officer
7
Clyde Road
Somerset,
New Jersey 08873
(732)
873-5133
(Name,
address, including zip code, and telephone number, including area code, of agent for service)
Copies
of communications to:
David
S. Song, Esq.
Mazzeo
Song P.C.
444
Madison Avenue, 4th Floor
New
York, New York 10022
(212)
599-0700
|
Approximate
date of commencement of proposed sale to the public:
This post-effective amendment is being filed to deregister all of the
unsold securities previously registered under the Registration Statement.
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933 check the following box.
[ ]
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration statement number of the earlier effective registration statement
for the same offering.
[ ]
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.
[ ]
If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.
[ ]
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer
[ ]
|
|
Accelerated
filer
[ ]
|
Non-Accelerated
filer
[ ]
(Do not check if a smaller reporting company)
|
Smaller
reporting company [X]
|
|
Emerging
growth company [X]
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act.[X]
EXPLANATORY
NOTE
On
December 1, 2016, Medical Transcription Billing, Corp. (the “Company”) filed a registration statement on Form S-1
with the Securities and Exchange Commission (SEC), File No.
333-214863, as amended by Amendment No.
1 to Form S-1 filed on December 12, 2016, Amendment No. 2 to Form S-1 filed on June 2, 2017, Amendment No. 3 to Form S-1 filed
on June 14, 2017, and Amendment No. 4 to Form S-1 filed on June 20, 2017 (the “Registration Statement”), to register
the sale of the Company’s Series A Preferred Stock. The Registration Statement was declared effective on June 22, 2017.
The
Company is filing this Post-Effective Amendment No. 1 to the Registration Statement to deregister all of the shares of Series
A Preferred Stock that have not been sold pursuant to the Registration Statement. Pursuant to the undertaking contained in the
Registration Statement to remove from registration any of the securities being registered which remain unsold at the termination
of the offering, the Company hereby amends the Registration Statement to remove from registration the shares of Series A Preferred
Stock covered by the Registration Statement which remain unsold.
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
capacities and on the dates indicated.
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Mahmud Haq
|
|
Chairman of the Board and Chief Executive
|
|
July 14, 2017
|
Mahmud Haq
|
|
Officer
(principal executive
officer)
|
|
|
|
|
|
|
|
/s/ Bill Korn
|
|
Chief Financial Officer
|
|
July 14, 2017
|
Bill Korn
|
|
(principal financial officer)
|
|
|
|
|
|
|
|
/s/ Norman Roth
|
|
Controller (principal accounting
officer)
|
|
July 14, 2017
|
Norman Roth
|
|
|
|
|
|
|
|
|
|
/s/ Stephen A. Snyder
|
|
President and Director
|
|
July 14, 2017
|
Stephen A. Snyder
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
July 14, 2017
|
Anne Busquet
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
July 14, 2017
|
Howard L. Clark, Jr.
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
July 14, 2017
|
John N. Daly
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
July 14, 2017
|
Cameron Munter
|
|
|
|
|
*
By:
|
/s/
Mahmud Haq
|
|
|
July
14, 2017
|
|
Mahmud Haq
|
|
|
|
|
Attorney-in-Fact
|
|
|
|
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Dec 2024 to Jan 2025
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Jan 2024 to Jan 2025